GCG and diabetes mellitus: Additionally, since incretin receptor expression is reduced in the advanced stage of diabetes mellitus, incretin-based medicine shows more favorable effects against β-cell glucose toxicity, especially in the early stage of diabetes mellitus compared to the advanced stage.